Biodelivery Sciences International Net Income

Biodelivery Sciences International (BDSI) currently reports a net income of $85M as of December 2021. That compares with $26M in the prior-year period — up 230.1% year over year. That is below the Healthcare sector average of $17B. Use the charts on this page to explore Biodelivery Sciences International's net income history and peer comparisons.

Biodelivery Sciences International's net income increased from $26M to $85M — a 230.1% year-over-year increase (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biodelivery Sciences International's net income of $85M is lower than the Healthcare sector average of $17B. That is roughly 99.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Biodelivery Sciences International reported $85M in net income as of December 2021. That compares with $26M in the prior-year period — up 230.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $85M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $17B. From there, open related valuation or income-statement pages for Biodelivery Sciences International, and consider following BDSI for alerts when major investors trade the stock.